Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Radiation Pneumonitis 1Pulmonary Embolism 1Neoplasms 1Mesothelioma 1Lung Diseases, Interstitial 1

Interventions

nintedanib 2durvalumab 2Radiotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1aumolertinib 1atezolizumab 1Tomography, Emission-Computed, Single-Photon 1Surveys and Questionnaires 1Respiratory Function Tests 1Prednisone 1Nivolumab 1Immunotherapy 1Immunoglobulin G 1Enalapril 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Adrenal Cortex Hormones 1Adjuvants, Immunologic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Pneumonitis × Acetylcysteine × Thoracic × Clear all
NCT05986318 2026-03-09

RESPIRE-ILD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Recruiting
98 enrolled
Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡